Free Trial
→ The next market Nvidia is positioned to dominate … (From Weiss Ratings) (Ad) Buy SRPT Stock  Free SRPT Stock Alerts

Sarepta Therapeutics (SRPT) SEC Filings & 10K Form

Sarepta Therapeutics logo
$62.40 +1.55 (+2.55%)
As of 04:00 PM Eastern
Compare

Recent Sarepta Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/24/2025
3:15 PM		Sarepta Therapeutics (Filer)
Form ARS
03/13/2025
7:00 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:33 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:05 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:32 PM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:38 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
7:30 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
11:25 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
12/16/2024
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:06 PM		Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:18 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:15 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/26/2024
6:17 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:40 AM		JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
11/13/2024
9:27 AM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
09/16/2024
7:00 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2024
7:05 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:51 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
4:03 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:00 AM		Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:50 PM		Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:01 PM		Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:35 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:16 PM		Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
3:45 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
12:30 PM		BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
05/06/2024
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/06/2024
7:09 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:01 PM		Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SRPT) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...
Paradigm Press | Sponsored
Elon Musk’s next move from the Oval Office?
No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...
Weiss Ratings | Sponsored
China’s next move could destroy U.S. tech
The U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...
Investors Alley | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
Top performing AI play of the decade…? (The answer will shock you)
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored